8-K: Adagio Medical Holdings Appoints Daniel George as Interim CFO

Adagio Medical Holdings appoints Daniel George as Interim Chief Financial Officer, effective April 17, 2025.

Summary

• Adagio Medical Holdings, Inc. appointed Daniel George as Interim Chief Financial Officer, principal financial officer, and principal accounting officer on April 17, 2025.
• Mr. George's compensation will be $400 per hour.
• He will be employed on an at-will basis.
• Mr. George, age 55, has a background in providing executive financial services to healthcare companies since December 2022.
• He also serves as part-time CFO of Anebulo Pharmaceuticals, Inc. since September 2023.
• Previously, he was the full-time CFO and Treasurer of Lucira Health, Inc. from August 2020 to November 2022.
• He has held various financial roles at companies like Avinger Inc., ApniCure, Inc., Avantis Medical Systems, Inc., and FoxHollow Technologies Inc.
• Mr. George holds B.S. degrees in Accounting and Finance from California State University, Long Beach.
• There are no family relationships between Mr. George and any of the Company's directors or executive officers.
• There are no arrangements between Mr. George and any other person pursuant to which Mr. George was selected as the Company's principal financial officer, nor are there any transactions to which the Company is or was a participant and in which Mr. George has a material interest subject to disclosure under Item 404(a) of Regulation S-K.

Sentiment

Score: 6

Explanation: The announcement is neutral, detailing a standard corporate action. The appointment of an interim CFO is neither overwhelmingly positive nor negative.

Positives

• Adagio Medical Holdings has appointed an experienced financial professional as Interim CFO.
• Daniel George's background includes significant experience in the healthcare industry, which could be beneficial for the company.
• The hourly rate of $400 provides flexibility for the company.

Risks

• The appointment is on an interim basis, which may create uncertainty regarding the long-term financial leadership of the company.
• The hourly rate of $400 could potentially become expensive depending on the number of hours required.

Future Outlook

The company will file the Offer Letter as an exhibit to its Quarterly Report on Form 10-Q for the three months ended March 31, 2025.

Industry Context

The appointment of an interim CFO is a common practice in the healthcare industry, especially during periods of transition or restructuring. Companies often seek experienced financial professionals with specific industry knowledge to fill these roles.

Comparison to Industry Standards

• Hourly rates for interim CFOs in the healthcare industry can vary widely depending on experience, company size, and location.
• Comparable companies might include other medical device or pharmaceutical firms that have recently appointed interim CFOs.
• It would be useful to compare the $400 hourly rate to industry benchmarks for similar roles to assess its competitiveness.

Management Changes

Stakeholder Impact

• Shareholders may view the appointment of an experienced Interim CFO positively, as it ensures continued financial oversight.
• Employees in the finance department will report to the Interim CFO.
• The appointment may have a limited impact on customers and suppliers.

Next Steps

• The Offer Letter will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the three months ended March 31, 2025.
• Adagio Medical Holdings may begin a search for a permanent CFO.

Key Dates

Keywords

CFO, Interim Chief Financial Officer, Daniel George, Adagio Medical Holdings, Appointment, Executive Financial Services, Healthcare, Financial Officer